Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Townsend Richard Nolan sold 55,000 Lexeo Therapeutics, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Townsend Richard Nolan (Director, Chief Executive Officer) sold 55,000 Lexeo Therapeutics, Inc. shares at US$5.69 for US$313K under a trading plan, leaving 340,106 shares. Filed Apr 7, 2026 (Form 4).

Sold
55,000 shares
Price
US$5.69
Value
US$313K
Holding after
340,106 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockSale55,000US$5.69340,106Direct

Source

View original at SEC

Related